A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE006 (GBR) · Dr. Rossi
consented 2023-09-03
AEs
4
Serious
0
Dropout signal
–
Adverse events
moderate
assessed
Grade 2 Constipation — outcome: RECOVERED/RESOLVED; onset 2024-03-15 (study day 188); relationship: not assessed
moderate
assessed
Grade 2 Alopecia — outcome: RECOVERED/RESOLVED; onset 2024-06-06 (study day 271); relationship: not assessed
mild
assessed
Grade 1 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2024-06-30 (study day 295); relationship: N
moderate
assessed
Grade 2 Alopecia — outcome: UNKNOWN; onset 2024-10-29 (study day 416); relationship: Y
Data queries
No data queries.